v3.25.2
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses:        
Research and development $ 7,509 $ 37,458 $ 38,146 $ 67,961
General and administrative 8,292 11,860 19,800 22,163
Restructuring, impairment, and costs of suspended programs 37,098   83,378  
Total operating expenses 52,899 49,318 141,324 90,124
Loss from operations (52,899) (49,318) (141,324) (90,124)
Interest income 3,269 4,987 7,207 9,992
Other expense, net (307) (17) (318) (27)
Net loss (49,937) (44,348) (134,435) (80,159)
Other comprehensive loss:        
Unrealized loss on marketable securities (105) (44) (300) (323)
Comprehensive loss $ (50,042) $ (44,392) $ (134,735) $ (80,482)
Net loss per share attributable to common stockholders, basic $ (1.04) $ (1.02) $ (2.8) $ (1.9)
Net loss per share attributable to common stockholders, diluted $ (1.04) $ (1.02) $ (2.8) $ (1.9)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic 48,133,609 43,344,345 47,993,622 42,170,123
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted 48,133,609 43,344,345 47,993,622 42,170,123